LEUNG GABRIEL
SEC Form 4 insider trading activity
LEUNG GABRIEL has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: Jun 5, 2026.
On the most recent filing, LEUNG GABRIEL is listed as Director at NovoCure Ltd. Inside the rolling window, LEUNG GABRIEL reported no open-market purchases and 1 open-market sale totaling $46K in NVCR.
Companies traded
Other insiders at NVCR
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$46K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has LEUNG GABRIEL made?
LEUNG GABRIEL has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company since 2026.
Which companies does LEUNG GABRIEL trade?
LEUNG GABRIEL has filed SEC Form 4 disclosures for 1 company, including NVCR.
When was LEUNG GABRIEL's most recent SEC Form 4 filing?
LEUNG GABRIEL's most recent SEC Form 4 filing on Tracefour is dated Jun 5, 2026.
What is LEUNG GABRIEL's total buy and sell value in the current window?
Inside the rolling retention window, LEUNG GABRIEL bought $0 and sold $46K based on SEC Form 4 filings.
What was LEUNG GABRIEL's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 2,945 NVCR shares on 2026-06-02, worth $46K, per SEC Form 4 filings.